Valuation: BOIRON

Market Cap 332M 364M 307M 277M 521M 33.98B 542M 3.7B 1.46B 18.34B 1.36B 1.34B 57.91B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 284M 311M 262M 237M 446M 29.08B 464M 3.17B 1.25B 15.69B 1.17B 1.14B 49.56B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
12.84%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+0.26%
Current month+2.14%
1 month+5.23%
3 months-27.10%
6 months-28.73%
Current year-36.96%
1 week 18.85
Extreme 18.85
19.25
1 month 17.45
Extreme 17.45
20.3
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
42.8
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.26%-28.86%-52.06% 364M
-1.54%-5.40%+28.64%+125.94% 1,232B
-2.16%-6.61%+30.75%+76.62% 656B
-1.28%-4.64%+20.55%+103.01% 506B
-0.84%-1.60%+28.95%+68.67% 382B
-2.51%-9.02%+40.66%+30.21% 340B
-3.01%-4.99%+24.75%+51.31% 294B
-2.54%-4.68%-2.34%+31.38% 278B
-0.35%-6.19%+27.97%+65.12% 240B
-0.67%-1.08%+29.72%+118.59% 210B
Average -1.55%-2.15%+20.08%+61.88% 414B
Weighted average by Cap. -1.75%-2.67%+26.65%+86.59%

Financials

2024 2025
Net sales 488M 535M 451M 407M 766M 49.96B 796M 5.44B 2.15B 26.96B 2.01B 1.96B 85.15B 501M 549M 463M 418M 787M 51.34B 819M 5.6B 2.21B 27.71B 2.06B 2.02B 87.51B
Net income 11.34M 12.43M 10.48M 9.46M 17.81M 1.16B 18.52M 127M 50.04M 627M 46.63M 45.65M 1.98B 32.64M 35.79M 30.18M 27.24M 51.3M 3.34B 53.32M 365M 144M 1.81B 134M 131M 5.7B
Net Debt -49.74M -54.54M -45.99M -41.5M -78.16M -5.1B -81.24M -555M -220M -2.75B -205M -200M -8.69B -47.86M -52.47M -44.25M -39.93M -75.2M -4.9B -78.17M -534M -211M -2.65B -197M -193M -8.36B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
26-11-19 €19.10 0.00% 258
26-11-18 €19.10 -0.78% 649
26-11-17 €19.25 +1.32% 1,291
26-11-16 €19.00 -1.04% 1,591
26-11-13 €19.20 +0.79% 1,710

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON